December 2014
Page 1 of 8
Lydia L. Ogden, PhD, MPP
lydia.ogden@icloud.com
+215-279-0033
Experience
Senior Executive Director
Global Vaccine Public Policy
Merck
(November 2012-Present)
Lead worldwide public policy engagement for Merck's Vaccines Division.
 Develop overarching public policy strategy and priorities for pediatric, adolescent,
and adult vaccines.
 Direct matrixed organization of 20 U.S. and global vaccine policy staff to provide
strategic and tactical guidance to subsidiaries in established and emerging markets.
 Shape the policy environment to advance Merck vaccine business objectives in public
and private markets.
 Progress Merck’s relationships with the principal external government and nongovernmental stakeholders influencing global vaccine policy.
 Identify and evolve key engagement opportunities for senior management with
external stakeholders on vaccines policy and programs.
 Deliver expert guidance on the role of vaccines in population health and building
sustainable immunization programs in a range of national economies and health
systems.
 Promote cross-functional collaboration among communications, medical affairs,
market access, marketing, and policy components to maximize strategic and tactical
objectives.
 Co-chair the Vaccines Committee of the International Federation of Pharmaceutical
Manufacturers & Associations (IFPMA), a global, non-profit, nongovernmental
organization representing the research-based pharmaceutical industry.
Director
Office of Health Reform Strategy, Policy, and Coordination
Office of the Associate Director for Policy
Office of the Director, Centers for Disease Control and Prevention
(August 2011-November 2012)
Led the CDC Office of Health Reform to achieve maximum population health impact by
leveraging health system transformation driven by the Affordable Care Act.
 Advised CDC leadership and programs on strategy to achieve population health goals
and guide public health transformation in response to health reform.
 Liaised with senior leadership in the Department of Health and Human Services,
other HHS operating divisions, and public and private partners to achieve strategic
aims.
 Monitored health reform implementation at federal, state, and local levels and
provided expert guidance on critical elements – e.g., state implementation of
Medicaid expansion and exchanges, determination of essential health benefits
packages, Medicare demonstrations.
 Built public health capacity and knowledge to address changes in U.S. and
comparative health systems: finance and payment structures, insurance, and care
delivery systems.
Lydia L. Ogden, PhD, MPP/December 2014
Page 2 of 8
Senior Policy Advisor
Office of Prevention Through Healthcare
Office of the Associate Director for Policy
Office of the Director, Centers for Disease Control and Prevention
(April 2010-August 2011)
Following the passage of health reform legislation in March 2010, assumed a senior
leadership role in the Office of Prevention Through Healthcare, part of the Associate Director
for Policy office within the CDC Office of the Director.
 Provided expert guidance to CDC programs on leveraging the U.S. health system to
achieve population-based health goals. Areas of specialization: Medicare, Medicaid,
private health insurance, long-term care, federalism and health, integrating clinical
and community preventive services.
 Conducted and oversaw analyses of health spending drivers, needed changes in care
delivery, and finance and payment levers to achieve reform.
 Liaised with other HHS agencies and Department staff to ensure coordinated efforts
to maximize health and value for the nation’s health spending.
 Served as the Associate Director for Science for the Office of the Associate Director for
Policy, responsible for assuring the quality of scientific and policy content in proposed
publications and external communications.
Senior Health Policy Advisor
The National Commission on Fiscal Responsibility and Reform
The White House
(June-December 2010)
**On detail from the Centers for Disease Control and Prevention (CDC)
The bipartisan National Commission on Fiscal Responsibility and Reform – known
informally as the Bowles Simpson Commission – was created in February 2010 by President
Obama and charged with making recommendations designed to balance the nation’s budget
by 2015. The Commission’s mandate was to propose policies that meaningfully improve the
long-run fiscal outlook, including changes to address the growth of entitlement spending and
the gap between the projected revenues and expenditures of the federal government. Duties
and responsibilities:
 Provided authoritative advice and counsel to the Commission Co-Chairs, former
White House Chief of Staff Erskine Bowles and Senator Alan Simpson, Executive
Director Bruce Reed (later chief of staff to Vice President Biden), and the full
Commission regarding health spending drivers and policies to increase value, curb
spending, preserve quality, and improve health outcomes.
 Worked with House and Senate staff (e.g., professional staff of the Senate Finance
and Budget Committees and House Ways and Means and Budget Committees,
Commission members’ personal staffs) to ensure transparency, solicit input, build
consensus around policy options, and manage expectations.
 Liaised with external experts and advocates to provide high-level policy information,
seek advice and counsel, build support for Commission recommendations, and
manage expectations.
 Conducted and oversaw in-depth analyses of policy reforms to inform deliberations
and recommendations.
 Developed and was lead author for health recommendations in the final Commission
report to President Obama, The Moment of Truth.
Lydia L. Ogden, PhD, MPP/December 2014
Page 3 of 8
Chief of Staff
Institute for Advanced Policy Solutions and
Center for Entitlement Reform, Emory University
(September 2007-March 2010)*
*Through interagency personnel agreement (IPA) with CDC
Directed strategic and daily operations management for two health policy think tanks:
formulated objectives and priorities; implemented and evaluated plans; revised as needed to
capitalize on opportunities and changes in environment. Responsibilities included:
 Developed health reform policy and research briefs for Congress, the Administration,
and other key decision-makers and stakeholders – e.g., prevention and health reform;
the role of coordinated care for medically complex patients in improving health
outcomes and reducing health spending; palliative care; medical loss ratios.
 Authored congressional testimony and academic articles on health services research –
e.g., incorporating prevention into health services; the impact of obesity on health
spending in the United States; secular trends in Medicare beneficiaries’ health
conditions, sources of care, and health spending.
 Represented Director and acted as his liaison to senior university leadership
(President, Provost, Deans), faculty, staff, students, and outside organizations and
individuals, including external funders.
 Directed internal and external marketing and communications, including
congressional testimony, speeches, blogs, and policy briefs.
 Developed networks and built alliances inside and outside the university;
collaborated across boundaries to build strategic relationships and achieve common
goals.
Adjunct Professor and Lecturer
Rollins School of Public Health
Emory University (September 2004-Present)
 Instructor, Health Policy and Management 500 and 503: Introduction to U.S. Health
System. Overview of U.S. health system (public and private sectors), financing and
payment, health service delivery, health reform, policy development, data for
decision-making, policy advocacy.
 Co-instructor, Health Policy and Management 572: Contemporary Health Policy
Issues. Builds sophisticated understanding of current and proposed policies for a set
of public health issues, including payment structures, long-term care, health care cost
drivers, reform proposals.
 Co-instructor, Health Policy and Management 575: Seminar in U.S. Health Policy.
The capstone course for Master’s-level students concentrates on the reform process in
the U.S. health care system; reviews major proposals for system reform; considers
likely mechanisms for implementing reforms in the United States; investigates
advanced topics in health policy, including governance and accountability models.
 Lecturer, Health Policy and Management 576: Policy Analysis: Analytic Applications,
on Uses of Data in Public Policy.
 Lecturer, Career MPH Program Global Health 515D: Introduction to Public Health
Surveillance, on Data for Public Health Policymaking.
 Lecturer, Global Health 501: Policies in Global Health, on Data for Global Health
Policymaking: HIV/AIDS, and on U.S. Health Reform: Implications for Global
Health.
Lydia L. Ogden, PhD, MPP/December 2014
Page 4 of 8
Deputy Chief of Staff for Policy
Centers for Disease Control and Prevention (February 2004-September 2005*)
Advised the Director, Chief of Staff, Chief Operating Officer, and other senior staff on
management of emergent policy issues, policy development, and strategic planning. Served
as point of contact and triage for Health and Human Services officials and other operating
divisions within HHS. Directed content and production of CDC’s annual health impact
report: The State of CDC. Oversaw speechwriting for CDC Director. Chief strategist for CDC’s
global health office; coordinated development of medium- and long-range strategic program
plans for international public health activities. Managed the Centers for Medicare and
Medicaid southeastern region’s education and enrollment campaign for the Medicare Part D
drug benefit while on Senior Executive Service (SES) developmental rotation.
**Pursued PhD in health policy (multidisciplinary program encompassing health
economics, health services research, health policy, statistical analysis and program
evaluation, political science) (September 2005-March 2010)
Associate Director for Policy and Planning
Global AIDS Program, Centers for Disease Control and Prevention (2001-2004)
As a member of the senior management team, helped lead the program through explosive
growth (from $105 million in FY01 to more than $500 million in FY04) and two highvisibility Presidential AIDS initiatives: to combat mother-to-child HIV transmission and to
provide prevention, care, and treatment in 15 of the world’s hardest-hit countries. Advised
the Director, Deputy Director, and senior staff on emergent policy issues, policy
development, and strategic planning, including prioritization and fiscal, human, and
technical resource allocation. Served as designated point of contact for HHS Secretary’s
Office of Global Health Affairs. Responded to inquiries from Congress, other components of
HHS, the Administration, other national governments, and external partners (e.g., WHO,
UNAIDS, NGOs, academia, private-sector entities). Analyzed specific policy concerns (e.g.,
antiretroviral policy, serosurveillance policy) and proposed solutions/actions. Supervised 4
direct reports and, as part of management team, approximately 100 staff and contractors.
Senior Policy Analyst, Office of Planning and Policy Coordination
Office of the Director, National Center for HIV, STD, and TB Prevention
Centers for Disease Control and Prevention (1999-2001)
Managed development of CDC’s five-year domestic and international HIV strategic plan.
Developed appropriate inputs and criteria for decision-making regarding $700+ million HIV
prevention programming; developed decision models. Audited HIV programming, research,
and surveillance activities. Ran agency-wide prioritization workgroup and five combined
internal/external planning groups encompassing more than 100 individuals. Conducted
briefings for external partners, U.S. government agencies, and HHS. Conducted public
comment review meetings. Developed policy recommendations. Responded to congressional
and other information requests. Staffed concurrent Institute of Medicine review of national
HIV prevention activities.
Senior Policy Analyst, Office of Program Planning and Evaluation
Office of the Director, Centers for Disease Control and Prevention (1998)
Prepared budget initiatives in cooperation with CDC Centers, Institute, and Offices,
including Financial Management Office. Analyzed authorizing environments — government
(federal, state, local; legislative, executive, judicial) and nongovernment (e.g., external
partners, media) — to effectively manage CDC policy issues. Prepared briefing memos,
reports, and presentations for the Director and other senior management. Reviewed
Lydia L. Ogden, PhD, MPP/December 2014
Page 5 of 8
submissions from agency components (legislative proposals, reports to Congress) for policy
implications. Conducted policy inventory for CDC, examining policy planning, analysis,
development, implementation, and evaluation.
John F. Kennedy School of Government
Harvard University (1996-1998)
Pursued training underwritten by CDC. Received a Master’s degree in Public Policy
(MPP) with dual concentration in Strategic Management of Government Organizations and
Networks and in Press, Politics and Public Policy. Coursework included micro and
macroeconomics, statistics, program evaluation, legislative and regulatory process, law and
public policy, strategic planning, budget development, polling/public opinion, and U.S.
health care policy.
Communications Specialist
National Center for HIV, STD, and TB Prevention
Centers for Disease Control and Prevention (1993-1996)
Developed responses to congressional inquiries, authored testimony, helped prepare
senior managers to testify before Congress and speak to media. Articulated CDC AIDS policy
in public fora (e.g., formal debates at the American Bar Association, National Conference of
State Legislatures) and to the media. Created, built, and maintained the Prevention
Collaborative, a public/private network of approximately 300 national, regional, state, and
local organizations, which functioned as a strategic policy advocacy coalition to address
HIV/AIDS issues in state and federal lawmaking bodies and in the national and local media.
Provided technical assistance to community-based and national organizations on HIV
prevention social marketing; program development, implementation, and evaluation; policy
development, implementation, and evaluation; and media and public relations. CDC lead on
the Condom Task Force, a cooperative venture among CDC, the Food and Drug
Administration, the National Institutes of Health, and America's leading condom
manufacturers. Lead author of Applying Prevention Marketing, a technical assistance
manual on using social marketing for effective HIV prevention program development,
implementation, and evaluation. Detailed from CDC to the White House Office of National
AIDS Policy to develop a strategic communications plan for that office, including issues
management, media relations, constituency development and mobilization, communications
with the legislative branch and within the executive branch.
Communications Specialist
Agency for Toxic Substances and Disease Registry (1989-1993)
Architect of the agency’s site-specific community involvement program, designed to
ensure public participation in agency decision-making at toxic waste sites nationwide.
Coordinated efforts of multiple federal and state and local agencies to avoid duplication of
services and promote unified public messaging. Developed responses to congressional
inquiries, authored testimony and speeches, helped prepare senior managers to testify and
speak to media. Author: Guidelines for Community Involvement, a how-to manual for
participatory agency decision-making; editor: The Public Health Implications of Medical
Waste: A Report to Congress.
Lydia L. Ogden, PhD, MPP/December 2014
Page 6 of 8
Education
BS, summa cum laude, Middle Tennessee State University, 1981. Dual concentration in
English and Education. (Certified to teach in Tennessee: grades K-12.)
MA, Vanderbilt University, 1984. Concentration in English Literature.
MPP, John F. Kennedy School of Government, Harvard University, 1998. Dual
concentration in Strategic Management of Government Organizations and Networks and in
Press, Politics and Public Policy.
PhD, Emory University, March 2010. Interdisciplinary course of study, encompassing U.S.
and comparative health policy, health economics, health services research, analytic
methods, and political science.
Other: Health and Human Services Senior Executive Service Candidate Development
Program (SES CDP), 2005. Completed two-year training and development program for the
Senior Executive Service of the U.S. government.
Other Qualifications
 Certified for Senior Executive Service (SES) March 2006.
 Security Clearance: Top Secret.
Selected Publications
Rein A, Ogden L. Public Health: A Best Buy for America [Invited Editorial]. Journal of
Public Health Management and Practice 2012; 18(4): 299-302.
Ogden L, Sellers K, Sammartino C, Buehler J, Bernet P. Funding Formulas for Public Health
Allocations: Federal and State Strategies. Journal of Public Health Management and
Practice 2012; 18(4): 309-316.
Ogden L. How Federalism Shapes Public Health Financing, Policy, and Program Options.
Journal of Public Health Management and Practice 2012; 18(4): 317-322.
Buehler J, Bernet P, Ogden L. Resource and Cost Adjustment in the Design of Allocation
Funding Formulas in Public Health Programs. Journal of Public Health Management and
Practice 2012; 18(4): 323-332.
Buehler J, Bernet P, Ogden L. Reference Allocations and Use of a Disparity Measure To
Inform the Design of Allocation Funding Formulas in Public Health Programs. Journal of
Public Health Management and Practice 2012; 18(4): 333-338.
Coates R, Yoon P, Zaza S, Ogden L, Thacker S. Rationale for Periodic Reporting on the Use
of Adult Clinical Preventive Services of Public Health Priority—United States. Morbidity and
Mortality Weekly Report Supplement June 15, 2012; 61(02);3-10.
Coates R, Ogden L, Monroe J, Buehler J, Yoon P, Collins J. Conclusions and Future
Directions for Periodic Reporting on the Use of Selected Adult Clinical Preventive Services —
United States. Morbidity and Mortality Weekly Report Supplement June 15, 2012;
61(02);73-78.
Lydia L. Ogden, PhD, MPP/December 2014
Page 7 of 8
Goetzel RZ, Staley P, Ogden L, et al. A Framework for Patient-Centered Health Risk
Assessments: Providing Health Promotion and Disease Prevention Services to Medicare
Beneficiaries. Centers for Disease Control and Prevention 2012; published online at:
http://www.cdc.gov/policy/opth/hra/FrameworkForHRA.pdf .
Ogden L, Richards C, Shenson D. Clinical Preventive Services for Older Adults: The
Interface Between Personal Health Care and Public Health Services. American Journal of
Public Health March 2012; 102(3): 419-425.
Ogden L. Financing and Organization of National Health Systems. In: Fried BJ, Gaydos LM,
editors. World Health Systems: Challenges and Perspectives, 2nd edition. Chicago: Health
Administration Press; pages 49-70.
Thorpe K, Ogden L. Community Health Teams: Costs and Outcomes. In: Young PL, Olsen
L, editors. The Healthcare Imperative: Lowering Costs and Improving Outcomes.
Washington, D.C.: Institute of Medicine; 2009. p. 408-415.
Thorpe K, Ogden L. The Foundation That Health Reform Lays For Improved Payment, Care
Coordination, And Prevention. Health Affairs June 2010; 29(5): 1183-1187.
Thorpe K, Ogden L, and Galactionova K. Chronic Conditions Account For Rise In Medicare
Spending From 1987 To 2006. Health Affairs April 2010; 29(4): 718-724.
Thorpe K, Ogden L. Creating the Virtual Integrated Delivery System. Health Affairs blog,
October 5. 2009. http://healthaffairs.org/blog/2009/10/05/creating-the-virtual-integrateddelivery-system/.
Thorpe K, Ogden L, Galactionova K. Weighty Matters: How Obesity Drives Poor Health and
Health Spending in the U.S. Washington, D.C.: National Business Group on Health, February
2009.
Ogden L, Adams K. From Poorhouse to Warehouse: Institutional Long-Term Care in the
United States. Publius: The Journal of Federalism 2009; 39(1): 138-163.
Ogden L. (2004). The Politics of Institutional Responses: CDC and the Controversy Over
Maternal and Newborn HIV Testing. In: Emerging Illnesses and Society. Packard R, Brown
P, Berkelman R, Frumkin H, eds. Baltimore: Johns Hopkins Press; pp 313-349.
Valdiserri R, Ogden L, Janssen R, Onorato I, Martin T. Aligning Budget with U.S. National
HIV Prevention Priorities. Journal of Public Health Management and Practice 2004; 10(2):
140-147.
Valdiserri R, Ogden L, McCray E. Accomplishments in HIV Prevention Science:
Implications for Stemming the Epidemic. Nature Medicine 2003; 9(7): 881-886.
Selected Presentations
“ABCD: AIDS, Birth Control & Death Panels—A View From the Front Lines.” Closing Plenary,
Religion as a Social Determinant of Health, Emory University; November 7, 2014.
“Opportunities and Challenges for Public Health in a Transforming U.S. Health System.”
Public Health Grand Rounds, Drexel University; October 24, 2013.
Lydia L. Ogden, PhD, MPP/December 2014
Page 8 of 8
“Red Light, Green Light: Barriers and Facilitators to HPV Vaccination Worldwide.” Emory
University; October 2, 2013.
“The Path to the New Public Health.” Closing Plenary, American Public Health Association
(APHA) Mid-Year Meeting; June 28, 2012.
“Implications of Health Reform for HIV/AIDS Prevention, Care, and Treatment.” National
Alliance of State and Territorial AIDS Directors (NASTAD) Annual Meeting; May 21, 2012.
“Clinical Preventive Services for Older Adults: The Interface Between Personal Health Care
and Public Health Services.” Older Americans Month Seminar, CDC; May 17, 2012.
“Overview of the Affordable Care Act and Implications for Public Health.” Board of Scientific
Counselors, Office of Infectious Diseases, CDC; May 1, 2012.
“Our Drive To Extend Life Is Killing Us.” TEDMed at CDC; April 11, 2012.
“Protecting Women’s Health: The Affordable Care Act Preventive Health Care Services.”
Society for Public Health Education (SOPHE), March 29, 2012.
“The Perfect Storm: U.S. Debt and Deficits.” CDC Grand Rounds; July 11, 2011.